Key result
AMI-CS survivors have ~85% higher one-year mortality versus no shock, mitigated by excellent inpatient care.
Why the study?
Long-term outcomes of acute myocardial infarction with cardiogenic shock survivors and the influence of inpatient care quality were unclear.
Does cardiogenic shock and inpatient care quality impact long-term mortality in acute myocardial infarction survivors?
Cohort (n=330,517)
Yes
Does cardiogenic shock and inpatient care quality impact long-term mortality in acute myocardial infarction survivors?
Answers are grounded in this paper and cite their sources.
Survivors of AMI with cardiogenic shock have a persistently elevated risk of long-term mortality up to 5 years compared to those without shock, though higher-quality inpatient care significantly improves long-term survival.
BACKGROUND: Acute myocardial infarction with cardiogenic shock (AMI-CS) carries a significant risk of inpatient mortality compared with AMI alone, although it is unclear what the longer-term outcomes of AMI-CS survivors is, and whether the inpatient quality of care received influences this. METHODS: Using the Myocardial Ischaemia National Audit Project (MINAP) registry, linked to Office for National Statistics (ONS) mortality data, we analyzed 330,517 UK AMI patients; 3330 (1 %) with CS. Patients dying within thirty-days of admission were excluded. Median follow-up for patients included was 1642 days. Cox regression models were fitted, adjusting for demographics and management strategy. RESULTS: AMI-CS survivors were younger (median years) (67 vs. 69, p < 0.001), less often female (29 % vs. 32 %, p < 0.001) and more likely to present with STEMI (81 % vs. 37 %, p < 0.001). Mortality risk was highest at one-year for AMI-CS survivors compared to patients that did not suffer CS (adjusted hazard ratio [HR] 1.85; 95 % CI; 1.68-2.04, p < 0.001), and remained elevated at five-years (HR 1.55; 95 % CI; 1.43-1.68, p < 0.001). 'Excellent-care' according to mean opportunity-based quality indicator (OBQI) score compared to 'Poor-care', showed reduced risk of long-term mortality with AMI-CS (HR: 0.46, CI; 0.39-0.54, P < 0.001). Of patients that received "Excellent-care", AMI-CS survivors had elevated risk of long-term mortality (HR 1.45, 95 % CI; 1.34-1.57, P < 0.001). CONCLUSION: AMI-CS survivors have elevated risk long-term mortality risk when compared with AMI patients, which persists beyond five years. AMI-CS patients that receive higher-quality inpatient care have better longer-term survival compared to those with poorer inpatient care.
No takes yet. Share an insight, caveat, or question.
Weight et al. (2024) conducted a cohort in Acute myocardial infarction with cardiogenic shock (n=330,517). Cardiogenic shock vs. No cardiogenic shock was evaluated on One-year mortality (HR 1.85, 95% CI 1.68-2.04, p=<0.001). AMI-CS survivors had a higher risk of one-year mortality than those without shock, though excellent inpatient care reduced long-term mortality risk.
Synapse has enriched 10 related papers. Consider them for comparative context: